drugset / Trial / NCT02207426
Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™
RandomizedCrossoverOpen-labelTreatment
Summary
This study compares pharmacokinetic profiles of tobramycin delivered by TobrAir® 6.0 device with TOBI® nebulizer system and the TOBI® Podhaler™ device. In addition, lung deposition of tobramycin delivered by TobrAir® 6.0 device and by TOBI® nebulizer system will be determined.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-08
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tobramycin | Small molecule | 75 mg | Inhaled |
| Subject | Tobramycin | Small molecule | 112 mg | Inhaled |
| Subject | Tobramycin | Small molecule | 300 mg | Inhaled |
Indications
No indication recorded.